Market Overview:
The global oxiracetam drugs market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising geriatric population, increasing prevalence of neurological disorders and growing demand for nootropic drugs. Based on type, the global oxiracetam drugs market is segmented into injection and capsule. Injection accounted for a major share of the global oxiracetam drugs market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to advantages such as ease of administration and high bioavailability offered by injection over other dosage forms. Capsule held second largest share in 2017 owing to benefits such as convenience of use and long shelf life offered by this dosage form over others. However, capsule is projected to witness highest CAGR during 2018-2030 owing to increasing preference for this dosage form among consumers across globe due its ease of swallowing and portability properties . Based on application, hospital segment accounted for majority share in 2017 followed by drug store segment owing higher adoption rateof oxiracetam drugs among healthcare professionalsfor various indicationssuch as dementiaand Alzheimer’s diseasein hospitals setting across globe .
Product Definition:
Oxiracetam is a nootropic agent derived from the racetam family. It is a water soluble cognitive enhancer that has been found to improve memory, learning, and concentration. Oxiracetam is also believed to enhance communication between the left and right hemispheres of the brain, making it an effective tool for reversing damage caused by stroke or other traumatic injuries.
Injection:
Injection is a form of oral drug delivery that involves the administration of drugs through an ampoule or a vial. Injection allows for more control over the dosage and it's efficacy as compared to other forms such as tablets and capsules. The most common route of administration used by pharmaceutical companies is via the buccal (chewing gum) route due to its ease in terms of application, high patient compliance, minimal adverse effects & low manufacturing costs involved.
Capsule:
Capsule is a hard gelatinous shell containing drug substance and it's used to protect the drug from degradation, oxidation, and interaction with other substances in the gastrointestinal tract. Capsules also provide controlled release of drugs which results in extended action of active ingredients over a longer period.
Oxiracetam capsules are available as both immediate-release (IR) capsules and modified-release capsules (MR).
Application Insights:
The other application segment dominated the global oxiracetam drugs market in 2017, accounting for over 60% share of the overall revenue. The segment includes prescription drugs used to treat Alzheimer¢â‚¬â„¢s disease, attention deficit hyperactivity disorder (ADHD), and Parkinson¢â‚¬â„¢s disease.
Oxiracetam is widely used as a nootropic drug for the treatment of neurological disorders such as ADHD and Alzheimer's disease. Moreover, it has been found to be useful in treating depression by enhancing brain function without any negative side effects reported so far. These factors are expected to drive product demand from other applications over the forecast period.
In addition, increasing awareness about mental health issues coupled with growing government initiatives concerning their reduction is anticipated to fuel market growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to high product demand and favorable reimbursement policies. The region is expected to witness substantial growth over the forecast period due to increasing geriatric population prone to cognitive impairment. Moreover, growing awareness about mental health among individuals and rising consumer spending on healthcare are also contributing toward market growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing with rapid economic development coupled with improving healthcare infrastructure in emerging countries such as China, India, Thailand, Singapore & South Korea. Growing prevalence of Alzheimer’s disease (AD) has led major pharmaceutical companies including Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Allergan Plc; Eisai Co., Ltd.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for oxiracetam drugs in the coming years.
- Rising prevalence of neurodegenerative diseases: The incidence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s is on the rise, which is likely to boost the demand for oxiracetam drugs in the near future.
- Growing awareness about benefits of oxiracetam drugs: There has been a growing awareness about the benefits of using oxiracetam drugs among healthcare professionals and consumers alike, which is likely to propel market growth in the coming years.
- Technological advancements in drug delivery systems: With technological advancements taking place at a rapid pace, there has been an increase in innovative drug delivery systems that can help improve absorption of oxiracetam drugs, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxiracetam Drugs Market Research Report
By Type
Injection, Capsule
By Application
Hospital, Drug Store, Other
By Companies
Haerbin Medisan, CSPC, North China Pharmaceutical Group, Langtian Pharmaceutical (Hube）, Ruiyang Pharmaceutical Co., Ltd, Guangdong Shixin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Oxiracetam Drugs Market Report Segments:
The global Oxiracetam Drugs market is segmented on the basis of:
Types
Injection, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haerbin Medisan
- CSPC
- North China Pharmaceutical Group
- Langtian Pharmaceutical (Hube）
- Ruiyang Pharmaceutical Co., Ltd
- Guangdong Shixin Pharmaceutical
Highlights of The Oxiracetam Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Capsule
- By Application:
- Hospital
- Drug Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxiracetam Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxiracetam is a nootropic drug that was first synthesized in the 1970s. It is often used to treat cognitive impairment and other conditions such as anxiety, depression, and ADHD.
Some of the key players operating in the oxiracetam drugs market are Haerbin Medisan, CSPC, North China Pharmaceutical Group, Langtian Pharmaceutical (Hube）, Ruiyang Pharmaceutical Co., Ltd, Guangdong Shixin Pharmaceutical.
The oxiracetam drugs market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oxiracetam Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oxiracetam Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oxiracetam Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oxiracetam Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oxiracetam Drugs Market Size & Forecast, 2018-2028
4.5.1 Oxiracetam Drugs Market Size and Y-o-Y Growth
4.5.2 Oxiracetam Drugs Market Absolute $ Opportunity
Chapter 5 Global Oxiracetam Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oxiracetam Drugs Market Size Forecast by Type
5.2.1 Injection
5.2.2 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oxiracetam Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oxiracetam Drugs Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oxiracetam Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oxiracetam Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oxiracetam Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Oxiracetam Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oxiracetam Drugs Market Size Forecast by Type
9.6.1 Injection
9.6.2 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oxiracetam Drugs Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oxiracetam Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Oxiracetam Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oxiracetam Drugs Market Size Forecast by Type
10.6.1 Injection
10.6.2 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oxiracetam Drugs Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oxiracetam Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oxiracetam Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oxiracetam Drugs Market Size Forecast by Type
11.6.1 Injection
11.6.2 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oxiracetam Drugs Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oxiracetam Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Oxiracetam Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oxiracetam Drugs Market Size Forecast by Type
12.6.1 Injection
12.6.2 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oxiracetam Drugs Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oxiracetam Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oxiracetam Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oxiracetam Drugs Market Size Forecast by Type
13.6.1 Injection
13.6.2 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oxiracetam Drugs Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oxiracetam Drugs Market: Competitive Dashboard
14.2 Global Oxiracetam Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haerbin Medisan
14.3.2 CSPC
14.3.3 North China Pharmaceutical Group
14.3.4 Langtian Pharmaceutical (Hube）
14.3.5 Ruiyang Pharmaceutical Co., Ltd
14.3.6 Guangdong Shixin Pharmaceutical
